A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications
Clinical trial NCT04353661 · TERMINATED
Trial details
- NCT number
- NCT04353661
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2023-06-29
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.